<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/atom+xml" href="https://feeds.transistor.fm/5-minute-pharma-daily" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>5-Minute Pharma Daily</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/5-minute-pharma-daily</itunes:new-feed-url>
    <description>Pharmaceutical and biotech news in 5 minutes. Drug approvals, clinical trials, and healthcare innovation.</description>
    <copyright>© 2025 Niche News</copyright>
    <podcast:guid>b903e7e2-9f26-5526-bb13-aab923c6f8db</podcast:guid>
    <podcast:locked owner="nichenews2000@gmail.com">no</podcast:locked>
    <language>en</language>
    <pubDate>Mon, 18 Aug 2025 09:46:22 +0100</pubDate>
    <lastBuildDate>Wed, 03 Dec 2025 07:21:08 +0000</lastBuildDate>
    <image>
      <url>https://img.transistor.fm/st2Tv7ILEy49AIegZUa1dz_xmt1fcD5arUI2hXry8HI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mNWE4/Yzc3MWYwMmYzYTgy/MGE3MDBlNWUxNTk3/ZTFlNy5wbmc.jpg</url>
      <title>5-Minute Pharma Daily</title>
    </image>
    <itunes:category text="Health &amp; Fitness"/>
    <itunes:category text="Business"/>
    <itunes:type>episodic</itunes:type>
    <itunes:author>Niche News</itunes:author>
    <itunes:image href="https://img.transistor.fm/st2Tv7ILEy49AIegZUa1dz_xmt1fcD5arUI2hXry8HI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mNWE4/Yzc3MWYwMmYzYTgy/MGE3MDBlNWUxNTk3/ZTFlNy5wbmc.jpg"/>
    <itunes:summary>Pharmaceutical and biotech news in 5 minutes. Drug approvals, clinical trials, and healthcare innovation.</itunes:summary>
    <itunes:subtitle>Pharmaceutical and biotech news in 5 minutes.</itunes:subtitle>
    <itunes:keywords>pharma, biotech, FDA, drugs, healthcare</itunes:keywords>
    <itunes:owner>
      <itunes:name>Niche News</itunes:name>
      <itunes:email>nichenews2000@gmail.com</itunes:email>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>Niche News Update: Returning Soon with Enhanced Coverage</title>
      <itunes:episode>5</itunes:episode>
      <podcast:episode>5</podcast:episode>
      <itunes:title>Niche News Update: Returning Soon with Enhanced Coverage</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d63d5ee1-f46e-43aa-9d0f-c8d6283ad6c4</guid>
      <link>https://share.transistor.fm/s/76aa86bb</link>
      <description>
        <![CDATA[<p>Niche News update on our upcoming relaunch with enhanced journalistic standards, <br>better source verification, and daily coverage across multiple topics. <br>We're returning soon with improved quality and uninterrupted service.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Niche News update on our upcoming relaunch with enhanced journalistic standards, <br>better source verification, and daily coverage across multiple topics. <br>We're returning soon with improved quality and uninterrupted service.</p>]]>
      </content:encoded>
      <pubDate>Mon, 18 Aug 2025 09:46:20 +0100</pubDate>
      <author>Niche News</author>
      <enclosure url="https://media.transistor.fm/76aa86bb/b2da70ef.mp3" length="1635266" type="audio/mpeg"/>
      <itunes:author>Niche News</itunes:author>
      <itunes:duration>100</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Niche News update on our upcoming relaunch with enhanced journalistic standards, <br>better source verification, and daily coverage across multiple topics. <br>We're returning soon with improved quality and uninterrupted service.</p>]]>
      </itunes:summary>
      <itunes:keywords>pharma, biotech, FDA, drugs, healthcare</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title> 5-Minute Pharma Daily August - 12, 2025</title>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title> 5-Minute Pharma Daily August - 12, 2025</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2adb0ce3-a559-44a4-8999-498c56c1a2c6</guid>
      <link>https://share.transistor.fm/s/e5f74147</link>
      <description>
        <![CDATA[FDA approves ketamine for surgical pain management as PharmaTher achieves historic milestone. Tonix Pharmaceuticals approaches critical fibromyalgia drug approval deadline.<p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[FDA approves ketamine for surgical pain management as PharmaTher achieves historic milestone. Tonix Pharmaceuticals approaches critical fibromyalgia drug approval deadline.<p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 12 Aug 2025 14:49:55 +0100</pubDate>
      <author>Niche News</author>
      <enclosure url="https://media.transistor.fm/e5f74147/f6109550.mp3" length="3232690" type="audio/mpeg"/>
      <itunes:author>Niche News</itunes:author>
      <itunes:duration>200</itunes:duration>
      <itunes:summary>
        <![CDATA[FDA approves ketamine for surgical pain management as PharmaTher achieves historic milestone. Tonix Pharmaceuticals approaches critical fibromyalgia drug approval deadline.<p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>pharma, biotech, FDA, drugs, healthcare</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>5-Minute Pharma Daily August - 11, 2025</title>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>5-Minute Pharma Daily August - 11, 2025</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">13679e4d-f226-4776-8e01-c104e2a9a327</guid>
      <link>https://share.transistor.fm/s/07a19f86</link>
      <description>
        <![CDATA[FDA grants accelerated approval for Jazz Pharmaceuticals' Modeyso, Biogen's Alzheimer's treatment awaits subcutaneous formulation decision, and RemeGen advances cancer therapy trials.<p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[FDA grants accelerated approval for Jazz Pharmaceuticals' Modeyso, Biogen's Alzheimer's treatment awaits subcutaneous formulation decision, and RemeGen advances cancer therapy trials.<p><br></p>]]>
      </content:encoded>
      <pubDate>Mon, 11 Aug 2025 15:27:54 +0100</pubDate>
      <author>Niche News</author>
      <enclosure url="https://media.transistor.fm/07a19f86/95829389.mp3" length="5623833" type="audio/mpeg"/>
      <itunes:author>Niche News</itunes:author>
      <itunes:duration>349</itunes:duration>
      <itunes:summary>
        <![CDATA[FDA grants accelerated approval for Jazz Pharmaceuticals' Modeyso, Biogen's Alzheimer's treatment awaits subcutaneous formulation decision, and RemeGen advances cancer therapy trials.<p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>pharma, biotech, FDA, drugs, healthcare</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>5-Minute Pharma Daily August - 10, 2025</title>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>5-Minute Pharma Daily August - 10, 2025</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">53bae68e-82b1-4d76-b100-fd6d753a1566</guid>
      <link>https://share.transistor.fm/s/5f0213ce</link>
      <description>
        <![CDATA[<p>The FDA launches its PreCheck Program to speed up approvals, while the FTC moves to block Edwards Lifesciences' acquisition of JenaValve. Leadership changes at an FDA center may impact future timelines.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>The FDA launches its PreCheck Program to speed up approvals, while the FTC moves to block Edwards Lifesciences' acquisition of JenaValve. Leadership changes at an FDA center may impact future timelines.</p>]]>
      </content:encoded>
      <pubDate>Sun, 10 Aug 2025 10:26:18 +0100</pubDate>
      <author>Niche News</author>
      <enclosure url="https://media.transistor.fm/5f0213ce/8156e54d.mp3" length="5386015" type="audio/mpeg"/>
      <itunes:author>Niche News</itunes:author>
      <itunes:duration>335</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>The FDA launches its PreCheck Program to speed up approvals, while the FTC moves to block Edwards Lifesciences' acquisition of JenaValve. Leadership changes at an FDA center may impact future timelines.</p>]]>
      </itunes:summary>
      <itunes:keywords>pharma, biotech, FDA, drugs, healthcare</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
